Dr. Ulrich Moebius has been appointed head of preclinical development and project management, MorphoSys. Dr. Moebius joins the company from Medigene AG, a German biopharmaceutical company, where for the last nine years, he held the position of head of preclinical development. He was responsible for the company’s preclinical activities in a range of development projects predominantly in cancer, and contributed to the market approval of two medical therapies. Prior to Medigene, he spent ...